COVID-19 Patient with Thrombosis and Acute Myocardial Infarction.
DOI:
https://doi.org/10.52428/20756208.v15i39.336Keywords:
Acute myocardial infarction, Anticoagulants, Coronavirus, SARS-CoV-2Abstract
One of the most studied assertions in SARSCoV-2 is the compromise of coagulation and the presence of thromboembolic diseases, with characteristic laboratory changes and a treatment that focuses on anticoagulation and, in some cases, fibrinolysis.
To date, it has not been possible to link classic disseminated intravascular coagulation with sepsis-induced coagulation, or pulmonary intravascular coagulation; often associated with ischemic stroke and acute myocardial infarction, poorly described. It is in this sense, that one of the treatment objectives in this pathology is to block hypercoagulation, without neglecting the endothelial dysfunction closely linked to thrombosis.
In this research work, we present a clinical case of a patient with the diagnosis of an acute coronary syndrome and the presence of SARS-CoV-2, who received anticoagulant and fibrinolytic treatment, happily with good evolution.
Downloads
References
Tang N, Bai H,Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease patients with coagulopathy 2019. Journal of thrombosis and haemostasis. 2020 Marzo; 18(5): p. 1094-1099. https://doi.org/10.1111/jth.14817 DOI: https://doi.org/10.1111/jth.14817
Bikdeli B. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention. Journal of the American College of Cardiology. 2020 Abril.
Barnes GD, Burnett B, Allen A, Blumenstein M. Thromboembolism and anticoagulant therapy during the COVID 19 pandemic: interim clinical guidance from the anticoagulation forum. Journal of Thrombosis and Thrombolysis. 2020 Mayo. https://doi.org/10.1007/s11239-020-02138-z DOI: https://doi.org/10.1007/s11239-020-02138-z
Pons S, Fodil S, Azoulay S, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Critical Care. 2020 Junio; 24(353). https://doi.org/10.1186/s13054-020-03062-7 DOI: https://doi.org/10.1186/s13054-020-03062-7
Belen Apak Burcu F. Pulmonary intravascular coagulation in COVID 19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy. Journal of Thrombosis and Thrombolysis. 2020 Mayo. https://doi.org/10.1007/s11239-020-02129-0 DOI: https://doi.org/10.1007/s11239-020-02129-0
Kloka FA, Kruipb MJHA, Van der Meerc NJM. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Research. 2020 Mayo. https://doi.org/10.1016/j.thromres.2020.04.013 DOI: https://doi.org/10.1016/j.thromres.2020.04.013
Recomendaciones de tromboprofilaxis y tratamiento antitrombótico en pacientes con COVID-19. [Online].; 2020 [cited 2020 Junio 23. Available from: https://www.covid-19.seth.es/recomendaciones-de-tromboprofilaxis-y-tratamiento-antitrombotico-en-pacientes-concovid-19/.
Bavishi Ch, Bonowb RO, Trivedi V. Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Progress in Cardiovascular Diseases. 2020 Septiembre;: p. 1-10. https://doi.org/10.1016/j.pcad.2020.05.013 DOI: https://doi.org/10.1016/j.pcad.2020.05.013
Helms J, Tacquard CH, Severac F, Leonard Lorant I. High risk of thrombosis in patients with severe SARS CoV 2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020. https://doi.org/10.1007/s00134-020-06062-x DOI: https://doi.org/10.1007/s00134-020-06062-x
Iba T, Levy JH, Levi M, ConnorsJM. Coagulopathy of Coronavirus Disease 2019. Critical Care Medicine. 2020 Mayo. https://doi.org/10.1097/CCM.0000000000004458 DOI: https://doi.org/10.1097/CCM.0000000000004458
Moreno G, Carbonell R, Bodi M. Revisión sistemática sobre la utilidad pronóstica del dímero-D, coagulación intravascular diseminada y tratamiento anticoagulante en pacientes graves con COVID19. Medicina Intensiva. 2020 Mayo;: p. 1-14. https://doi.org/10.1016/j.medin.2020.06.006 DOI: https://doi.org/10.1016/j.medin.2020.06.006
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Rommer Alex Ortega Martínez, Gabriela Vaca Mendoza
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
